Loxo Oncology, Inc.
Overview
Loxo Oncology, Inc. is a subsidiary of Eli Lilly and Company, specializing in the development of highly selective medicines for patients with genetically defined cancers. The company's mission is to create and deliver breakthrough treatments for cancer patients with significant unmet medical needs.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Loxo Oncology, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Loxo Oncology, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.